2010
Diclofenac sodium DR tablets 25 mg & 50 mg – ANDA Approval received). Tinidazole Tablets 250mg & 500mg – ANDA Filed |
| |
2009
Ornidazole P Ointment – R & D has developed anti-infective Ornidazole P Ointment topical gel. Clinical trails completed successfully. |
| |
2008
Cilnidipine, a new type of dihydropyridine, for hypertension, successfully developed at API, R&D. R & D has completed optimizing the formula & process for an antihypertensive Cilnidipine tablets 10/20 mg. |
| |
2007
R&D has developed Cough Suppressant Lozenges using ion exchange mechanism for bitter taste masking of drug. |
| |
2006
Gastrografin contrast media solution development completed for ANDA. |
| |
2005
R & D worked on many ANDA’s for filing with US FDA. Fluconazole Tablets ANDA for 50/100/200 mg has been approved. In Novel drug delivery systems. R & D has completed optimizing the formula & process for platform technology using osmotically controlled drug delivery system. The R & D laboratory has successfully developed a process for Gadopentetic Acid, which is used for formulating MRI contrast medium. |
| |
2004
The formulations developed like Quinolone antibacterials for example Ciprofloxacin 250/500/750 mg for ANDA filing. R & D has also developed Ciprofloxacin XR once daily dosage by using patented gastro retentive system. |
| |
2003
Pioneered a revolutionary new process for the manufacture of Metronidazole from its basic stage. |
| |
2002
• Two product patents from US Patent & Trade mark office for topical application of Metronidazole and PVP iodine.
• Second company in India to receive Drug controller General of India’s permission to market Ofloxacin Once-Daily 400mg & 800mg Formulations.
• J.B.Chemicals & Pharmaceuticals Ltd. is the first Indian and Asian Company to obtain the prestigious new EP4 European Certification for its Active Pharmaceutical Ingredient (API) – Nifedipine, Metronidazole & Diclofenac Sodium. |
| |
2000
Two product patents from US Patent & Trade mark office for Dental Formulations |
| |
1999
Developed several novel formulations, the significant ones being Metrogyl Denta and Metrogyl V Gel. |
| |
1998
US Patent for novel pharmaceuticals formulation of Metronidazole for Dental application. |
| |
1996
Patent for Controlled Release Formulation of Nifedipine in South Africa, Kazakhstan and Czech Republic. |
| |
1996
Patent of Doktor Mom Herbal Cough Remedy in Russia and Kazakhstan. |
| |
1995 / 1996
Patent of Controlled Release Formulation of Ranitidine in USA and South Africa. |
| |
 Top |
| |
| |
| R & D Milestones |
Quality | Technology
| Patents |